SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,239,000 | -19.1% | 3,364,895 | 0.0% | 2.95% | -0.5% |
| Q1 2022 | $4,004,000 | -65.3% | 3,364,895 | -4.9% | 2.97% | -26.4% |
| Q4 2021 | $11,540,000 | -24.9% | 3,539,895 | +2.9% | 4.03% | -10.8% |
| Q3 2021 | $15,376,000 | -18.0% | 3,439,895 | 0.0% | 4.52% | -2.9% |
| Q2 2021 | $18,747,000 | -20.2% | 3,439,895 | +9.6% | 4.66% | +3.4% |
| Q1 2021 | $23,486,000 | -18.1% | 3,139,895 | +18.8% | 4.50% | -8.3% |
| Q4 2020 | $28,671,000 | – | 2,642,500 | – | 4.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |